Trial Profile
The phase I trial of IVA-337 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2015
Price :
$35
*
At a glance
- Drugs Lanifibranor (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Inventiva Pharma
- 14 Aug 2015 New trial record